Company Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.

Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers.

The company is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd.

Country	Israel
Founded	2015
Industry	Biotechnology
Sector	Healthcare
Employees	125
CEO	Uzi Sofer

Contact Details

Address: Kiryat HaMada St. 5 Jerusalem, 9777605 Israel
Phone	972 3 577 4115
Website	alphatau.com

Stock Details

Ticker Symbol	DRTS
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001871321
CUSIP Number	M0740A108
ISIN Number	IL0011839383
SIC Code	3841

Key Executives

Name	Position
Uzi Sofer	Chief Executive Officer and Chairman
Raphi Levy	Chief Financial Officer
Amnon Gat	Chief Operations Officer
Ronen Segal	Chief Technology Officer
Dr. Robert B. Den M.D.	Chief Medical Officer and Member of Scientific Advisory Board
Prof. Yona Keisari	Chief Scientific Officer and Member of Scientific Advisory board
Rebecca Becker	Vice President of legal
Peter M. Melnyk	Chief Commercial Officer
Prof. Itzhak Kelson	Chief Physics Officer and Member of Scientific Advisory Board
Yael Zeiger	Corporate Controller

Latest SEC Filings

Date	Type	Title
Aug 11, 2025	6-K	Report of foreign issuer
Jul 24, 2025	SCHEDULE 13G	Filing
Jul 2, 2025	EFFECT	Notice of Effectiveness
Jun 27, 2025	UPLOAD	Filing
Jun 23, 2025	F-3	Filing
Jun 17, 2025	6-K	Report of foreign issuer
May 28, 2025	6-K	Report of foreign issuer
May 19, 2025	6-K	Report of foreign issuer
May 13, 2025	6-K	Report of foreign issuer
May 12, 2025	6-K	Report of foreign issuer

View All SEC Filings